RJFSA
NVO

Raymond James Financial Services Advisors’s Novo Nordisk NVO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$66.2M Sell
555,642
-44,069
-7% -$5.88M 0.09% 221
2024
Q2 		$85.6M Buy
599,711
+58,357
+11% +$7.73M 0.12% 165
2024
Q1 		$69.5M Buy
541,354
+51,844
+11% +$6.17M 0.1% 190
2023
Q4 		$50.6M Buy
489,510
+129,739
+36% +$12.8M 0.08% 232
2023
Q3 		$32.7M Buy
359,771
+66,949
+23% +$5.9M 0.06% 308
2023
Q2 		$23.7M Sell
292,822
-20,234
-6% -$1.65M 0.04% 407
2023
Q1 		$24.9M Buy
313,056
+72,876
+30% +$5.17M 0.05% 370
2022
Q4 		$16.3M Buy
240,180
+18,884
+9% +$1.11M 0.03% 483
2022
Q3 		$11M Sell
221,296
-25,436
-10% -$1.36M 0.02% 580
2022
Q2 		$13.7M Sell
246,732
-88,658
-26% -$4.92M 0.03% 520
2022
Q1 		$18.6M Buy
335,390
+8,580
+3% +$440K 0.04% 471
2021
Q4 		$18.3M Buy
326,810
+164
+0.1% +$8.88K 0.03% 480
2021
Q3 		$15.7M Buy
326,646
+7,628
+2% +$369K 0.03% 515
2021
Q2 		$13.4M Buy
319,018
+5,132
+2% +$199K 0.03% 562
2021
Q1 		$10.6M Buy
313,886
+93,580
+42% +$3.33M 0.02% 603
2020
Q4 		$7.69M Sell
220,306
-165,318
-43% -$5.71M 0.02% 663
2020
Q3 		$13.4M Buy
385,624
+116,314
+43% +$3.88M 0.04% 413
2020
Q2 		$8.82M Buy
269,310
+77,214
+40% +$2.46M 0.03% 500
2020
Q1 		$5.78M Buy
192,096
+7,216
+4% +$215K 0.03% 501
2019
Q4 		$5.35M Buy
184,880
+7,028
+4% +$195K 0.02% 707
2019
Q3 		$4.6M Sell
177,852
-64,416
-27% -$1.63M 0.02% 731
2019
Q2 		$6.18M Sell
242,268
-15,432
-6% -$381K 0.02% 603
2019
Q1 		$6.74M Buy
257,700
+1,236
+0.5% +$30.4K 0.03% 549
2018
Q4 		$5.91M Sell
256,464
-37,694
-13% -$838K 0.03% 481
2018
Q3 		$6.93M Buy
294,158
+3,248
+1% +$79.3K 0.03% 524
2018
Q2 		$6.71M Buy
290,910
+85,876
+42% +$2.04M 0.03% 500
2018
Q1 		$5.05M Buy
205,034
+21,776
+12% +$572K 0.03% 544
2017
Q4 		$4.92M Buy
183,258
+18,036
+11% +$459K 0.03% 545
2017
Q3 		$3.98M Sell
165,222
-18,750
-10% -$424K 0.03% 621
2017
Q2 		$3.94M Buy
183,972
+2,336
+1% +$47.1K 0.03% 595
2017
Q1 		$3.11M Sell
181,636
-236,994
-57% -$4.13M 0.02% 638
2016
Q4 		$7.51M Buy
418,630
+7,132
+2% +$129K 0.06% 332
2016
Q3 		$8.56M Buy
411,498
+3,480
+0.9% +$86.3K 0.08% 295
2016
Q2 		$11M Sell
408,018
-3,734
-0.9% -$102K 0.11% 235
2016
Q1 		$11.2M Buy
411,752
+5,918
+1% +$159K 0.13% 197
2015
Q4 		$11.8M Buy
405,834
+11,956
+3% +$331K 0.14% 194
2015
Q3 		$10.7M Buy
393,878
+217,860
+124% +$6.17M 0.18% 141
2015
Q2 		$4.82M Buy
+176,018
New +$4.95M 0.34% 70
2013
Q3 		– Sell
-261,400
Closed -$4.05M – 797
2013
Q2 		$4.05M Buy
+261,400
New +$4.35M 0.12% 202

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Raymond James Financial Services Advisors's NVO Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Novo Nordisk (NVO) stake by 7.3% in Q3 2024, selling an estimated $5.88M and leaving 555,642 shares worth $66.2M. The position accounts for 0.09% of the portfolio, ranked #221.

Raymond James Financial Services Advisors first reported a position in NVO in Q2 2013 and has held it in 39 quarters since. The position peaked at $85.6M in Q2 2024. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Raymond James Financial Services Advisors held 555,642 shares of Novo Nordisk worth $66.2M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 44,069 Novo Nordisk shares in Q3 2024, an estimated $5.88M.
  • Novo Nordisk made up 0.09% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #221 holding.
  • Raymond James Financial Services Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 39 quarters since.
  • Raymond James Financial Services Advisors's Novo Nordisk position peaked at $85.6M in Q2 2024.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.